FDA Inspection
Hospira Zagreb d.o.o.Hospira Zagreb d.o.o. – FDA Inspection, Nov 7, 2023
Record Details
This FDA Inspection record concerns Hospira Zagreb d.o.o., with an inspection on November 7, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 44865511-9c08-4b4a-bf39-0fe676c1561a
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1225278
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of Hospira Zagreb d.o.o.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| December 16, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 20, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hospira Zagreb d.o.o.
- FDA Inspection 1226933 - 2021-12-16
- FDA Inspection 1123692 - 2019-03-22
- FDA Inspection 1051780 - 2018-02-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.